Fundraising Fox

Biotech Investors & VC Firms in United Kingdom

137 firms in this list, with a median first check of $500K. 8 of them lead rounds. Generated from verified public data and updated continuously.

SV Health Investors
BostonPre-Seed–Late Stage$1M – $20M
17 people
Cambridge Innovation Capital
Cambridge, CambsSeed–Late Stage$127K – $12.7M
59 people
Basecamp Fund
ManchesterPre-Seed–Late Stage$100K – $10M
13 people
Giant Ventures Global Llp
LondonPre-Seed–Late Stage
30 people
Advent Life Sciences
LondonSeed–Late Stage
25 people
Novo Holdings
CopenhagenPre-Seed–Late Stage$1.1M – $54M
35 people
SR One Capital Management
Redwood CitySeed–Series B
25 people
Syncona
LondonPre-Seed–Late Stage
33 people
Apple Tree Venture Management Llc
New YorkPre-Seed–Late Stage
20 people
Oxford Science Enterprises
OxfordPre-Seed–Growth$63.5K – $31.8M
11 people
EMV Capital
LondonPre-Seed–Series B
20 people
In-Q-Tel
TysonsSeed–Series A$100K – $2.5M
11 people
Epidarex Capital
BethesdaPre-Seed–Series A$2.5M – $6.3M
9 people
4BIO Capital
LondonPre-Seed–Series B
26 people
Systemiq Capital
LondonSeries A–Growth
8 people
Delin Ventures
LondonPre-Seed–Series A$216K – $2.2M
21 people
NSV
GreenwichSeed–Late Stage$2M – $8M
7 people
Samsung Ventures
Menlo ParkSeed–Late Stage
22 people
Heran Partners
AntwerpSeed–Series B
12 people
Marathon Venture Capital
AthensSeed–Series B$250K – $1M
4 people
Georgian
Toronto, OntarioSeries B–Late Stage$25M – $100M
11 people
Parkwalk Advisors
LondonSeed–Growth
11 people
Blume Ventures
MumbaiSeed–Late Stage$50K – $300K
11 people
b2venture
BerlinPre-Seed–Late Stage$270K – $5.4M
11 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.